{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:29:31Z","timestamp":1761488971448,"version":"3.40.5"},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:p>A focused and commented review on the impact of dermatologic diseases and interventions in the solidary act of donating blood is presented to dermatologists to better advise their patients. This is a review of current Brazilian technical regulations on hemotherapeutic procedures as determined by Ministerial Directive #1353\/2011 by the Ministry of Health and current internal regulations of the Hemotherapy Center of Ribeir\u00e3o Preto, a regional reference center in hemotherapeutic procedures. Criteria for permanent inaptitude: autoimmune diseases (&gt;1 organ involved), personal history of cancer other than basal cell carcinoma, severe atopic dermatitis or psoriasis, pemphigus foliaceus, porphyrias, filariasis, leprosy, extra pulmonary tuberculosis or paracoccidioidomycosis, and previous use of etretinate. Drugs that impose temporary ineligibility: other systemic retinoids, systemic corticosteroids, 5-alpha-reductase inhibitors, vaccines, methotrexate, beta-blockers, minoxidil, anti-epileptic, and anti-psychotic drugs. Other conditions that impose temporary ineligibility: occupational accident with biologic material, piercing, tattoo, sexually transmitted diseases, herpes, and bacterial infections, among others. Discussion: Thalidomide is currently missing in the teratogenic drugs list. Although finasteride was previously considered a drug that imposed permanent inaptitude, according to its short halflife current restriction of 1 month is still too long. Dermatologists should be able to advise their patients about proper timing to donate blood, and discuss the impact of drug withdrawal on treatment outcomes and to respect the designated washout periods.<\/jats:p>","DOI":"10.1590\/s0365-05962012000400012","type":"journal-article","created":{"date-parts":[[2012,8,13]],"date-time":"2012-08-13T03:03:35Z","timestamp":1344827015000},"page":"590-595","source":"Crossref","is-referenced-by-count":4,"title":["Brazilian blood donation eligibility criteria for dermatologic patients"],"prefix":"10.1590","volume":"87","author":[{"given":"Carlos Gustavo","family":"Wambier","sequence":"first","affiliation":[{"name":"University of S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Silva","family":"Pereira","sequence":"additional","affiliation":[{"name":"University of Ribeir\u00e3o Preto,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedito de Pina Almeida","family":"Prado J\u00fanior","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma Tiraboschi","family":"Foss","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"journal-title":"Di\u00e1rio Oficial [da] Rep\u00fablica Federativa do Brasil","first-page":"27","year":"2011","key":"ref1"},{"journal-title":"Di\u00e1rio Oficial [da] Rep\u00fablica Federativa do Brasil","first-page":"68","year":"2004","key":"ref2"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1590\/S0365-05962006000600010","article-title":"Porfiria cut\u00e2nea tardia","volume":"81","author":"Vieira FMJ","year":"2006","journal-title":"An Bras Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0365-0596","issn-type":"print"},{"key":"ref4","first-page":"1","article-title":"The treatment of porphyria cutanea tarda by venesection","volume":"43","author":"Ramsay CA","year":"1974","journal-title":"Q J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0033-5622","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510270142","article-title":"Mutations in the hemochromatosis gene, porphyria cutanea tarda and iron overload","volume":"27","author":"Elder GH","year":"1998","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0161-0538","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2007-1007142","article-title":"Porphyria cutanea tarda","volume":"18","author":"Elder GH","year":"1998","journal-title":"Semin Liver Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0272-8087","issn-type":"print"},{"key":"ref7","first-page":"321","article-title":"Role of hepatitis C virus in porphyria cutanea tarda hepatopathy","volume":"106","author":"Quecedo L","year":"1996","journal-title":"Med Clin"},{"key":"ref8","first-page":"279","article-title":"Porphyria cutanea tarda and hepatitis C virus and B virus infection: a retrospective study","volume":"21","author":"Navas S","year":"1995","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0161-0538","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1258\/0956462991912944","article-title":"Porphyria cutanea tarda and HIV\/AIDS: a review of pathogenesis, clinical manifestations and management","volume":"10","author":"Mansourati FF","year":"1999","journal-title":"Int J STD AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0956-4624","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3810\/pgm.1999.04.691","article-title":"Porphyria cutanea tarda: Don't forget to look at the urine","volume":"105","author":"Rich MW","year":"1999","journal-title":"Postgrad Med","ISSN":"https:\/\/id.crossref.org\/issn\/0032-5481","issn-type":"print"},{"key":"ref11","series-title":"Dermatology in General medicine","first-page":"1854","volume-title":"The porphyrias","author":"Bickers DR","year":"1995","edition":"4"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1365-2362.2010.02334.x","article-title":"Polycythemia vera-associated pruritus and its management","volume":"40","author":"Saini KS","year":"2010","journal-title":"Eur J Clin Invest","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2972","issn-type":"print"},{"year":"2001","series-title":"Guidance for Industry: Variances for Blood Collection from Individuals with Hereditary Hemochromatosis","key":"ref13"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2133.1996.tb06977.x","article-title":"Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection","volume":"134","author":"S\u00e1nchez-P\u00e9rez J","year":"1996","journal-title":"Br J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0007-0963","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1590\/S0036-46651990000500010","article-title":"Soropositividade para HIV em doentes de herpes zoster","volume":"32","author":"Vasconcellos MR","year":"1990","journal-title":"Rev Inst Med Trop Sao Paulo","ISSN":"https:\/\/id.crossref.org\/issn\/0036-4665","issn-type":"print"},{"key":"ref16","first-page":"43","article-title":"Anti-PGL1 levels in leprosy patients and their contacts","volume":"26","author":"Foss NT","year":"1993","journal-title":"Braz J Med Biol Res","ISSN":"https:\/\/id.crossref.org\/issn\/0100-879X","issn-type":"print"},{"key":"ref17","series-title":"Uso racional de medicamentos: temas selecionados","first-page":"1","volume":"2","author":"Castro CO","year":"2005"},{"key":"ref18","series-title":"Comprehensive Dermatologic Drug Therapy","first-page":"488","author":"Wolverton SE","year":"2007","edition":"2"},{"key":"ref19","first-page":"737","article-title":"Acitr\u00e9tine","volume":"128","author":"Berbis P","year":"2001","journal-title":"Ann Dermatol Venereol","ISSN":"https:\/\/id.crossref.org\/issn\/0151-9638","issn-type":"print"},{"issue":"649-61","key":"ref20","article-title":"Treatment of psoriasis: Part 2. Systemic therapies","volume":"45","author":"Lebwohl M","year":"2001","journal-title":"J Am Acad Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0190-9622","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1365-2133.2000.03883.x","article-title":"Acitretin is converted to etretinate only during concomitant alcohol intake","volume":"143","author":"Gr\u00f8nh\u00f8j Larsen F","year":"2000","journal-title":"Br J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0007-0963","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0190-9622(99)70359-2","article-title":"Acitretin in psoriasis: An overview of adverse effects","volume":"41","author":"Katz HI","year":"1999","journal-title":"J Am Acad Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0190-9622","issn-type":"print"},{"key":"ref23","first-page":"133","article-title":"Resolu\u00e7\u00e3o - RDC n\u00ba 343, de 13 de dezembro de 2002.: Regulamento T\u00e9cnico dos Servi\u00e7os de Hemoterapia. Resolu\u00e7\u00e3o.","year":"2002","journal-title":"Di\u00e1rio Oficial [da] Rep\u00fablica Federativa do Brasil"},{"year":"2008","series-title":"(dutasteride) - Prescribing information","key":"ref24"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v87n4\/v87n4a12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:41Z","timestamp":1747666841000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962012000400012&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0365-05962012000400012"],"URL":"https:\/\/doi.org\/10.1590\/s0365-05962012000400012","relation":{},"ISSN":["0365-0596"],"issn-type":[{"type":"electronic","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}